| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001580 | Detection of chemical stimulus involved in sensory perception of bitter taste | Increases phenotype | PMID:22384968 |
| GO:0002118 | Aggressive behavior | Increases phenotype | PMID:31068541 |
| GO:0004303 | Estradiol 17-beta-dehydrogenase activity | Decreases phenotype | PMID:29578053 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:36038036 |
| GO:0004602 | Glutathione peroxidase activity | Affects phenotype | PMID:23921912; PMID:25882089; PMID:34047416 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:29896988; PMID:34047416 |
| GO:0006534 | Cysteine metabolic process | Increases phenotype | PMID:39441382 |
| GO:0006541 | Glutamine metabolic process | Increases phenotype | PMID:39441382 |
| GO:0006590 | Thyroid hormone generation | Decreases phenotype | PMID:27216871; PMID:27233481; PMID:27902923 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:34047416 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:25371773; PMID:34047416 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:25882089 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:10718548 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:34047416 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:19059302; PMID:35871495 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:21629661; PMID:29347925 |
| GO:0007268 | Chemical synaptic transmission | Increases phenotype | PMID:12933695 |
| GO:0007420 | Brain development | Decreases phenotype | PMID:27216871 |
| GO:0007611 | Learning or memory | Decreases phenotype | PMID:27233481; PMID:35869475 |
| GO:0007612 | Learning | Decreases phenotype | PMID:27216871 |
| GO:0007613 | Memory | Affects phenotype | PMID:29796989 |
| GO:0007631 | Feeding behavior | Affects phenotype | PMID:31068541 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:23517243; PMID:34047416 |
| GO:0008283 | Cell population proliferation | Affects phenotype | PMID:29578053; PMID:39441382; PMID:7531505; PMID:7531505; PMID:7819453 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:32949729; PMID:36506574 |
| GO:0008542 | Visual learning | Decreases phenotype | PMID:26606422; PMID:29796989 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:29578053 |
| GO:0010459 | Negative regulation of heart rate | Increases phenotype | PMID:30769017 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:25371773 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:25371773 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:25882089; PMID:25882089; PMID:26459835; PMID:34047416 |
| GO:0019530 | Taurine metabolic process | Increases phenotype | PMID:39441382 |
| GO:0021542 | Dentate gyrus development | Affects phenotype | PMID:33150595 |
| GO:0021884 | Forebrain neuron development | Decreases phenotype | PMID:22987596 |
| GO:0021954 | Central nervous system neuron development | Decreases phenotype | PMID:28973696 |
| GO:0030899 | Calcium-dependent atpase activity | Decreases phenotype | PMID:29896988 |
| GO:0031987 | Locomotion involved in locomotory behavior | Increases phenotype | PMID:31068541 |
| GO:0034276 | Kynurenic acid biosynthetic process | Increases phenotype | PMID:32663543 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:29578053 |
| GO:0036093 | Germ cell proliferation | Decreases phenotype | PMID:29578053 |
| GO:0036211 | Protein modification process | Affects phenotype | PMID:23921912 |
| GO:0042048 | Olfactory behavior | Affects phenotype | PMID:36706583 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:25060363; PMID:25060363; PMID:29896988; PMID:34047416; PMID:37295576; PMID:39441382; PMID:29896988; PMID:34047416; PMID:37295576; PMID:39441382; PMID:34047416; PMID:34047416; PMID:37295576; PMID:37295576 |
| GO:0042593 | Glucose homeostasis | Affects phenotype | PMID:34234489 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:33462684; PMID:36506574 |
| GO:0043066 | Negative regulation of apoptotic process | Increases phenotype | PMID:25298361 |
| GO:0043525 | Positive regulation of neuron apoptotic process | Increases phenotype | PMID:33603838; PMID:34609722 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:34234489 |
| GO:0045907 | Positive regulation of vasoconstriction | Increases phenotype | PMID:36942326 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:32949729 |
| GO:0046466 | Membrane lipid catabolic process | Affects phenotype | PMID:15473886; PMID:19174171; PMID:1991336 |
| GO:0050667 | Homocysteine metabolic process | Increases phenotype | PMID:39441382 |
| GO:0060112 | Generation of ovulation cycle rhythm | Affects phenotype | PMID:27902923 |
| GO:0061370 | Testosterone biosynthetic process | Decreases phenotype | PMID:29578053 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:34047416 |
| GO:0102727 | 3beta-hydroxysteroid dehydrogenase activity | Decreases phenotype | PMID:29578053 |
| GO:0110090 | Positive regulation of hippocampal neuron apoptotic process | Increases phenotype | PMID:31885695 |
| GO:1900272 | Negative regulation of long-term synaptic potentiation | Increases phenotype | PMID:26606422 |
| GO:1900409 | Positive regulation of cellular response to oxidative stress | Increases phenotype | PMID:31414343 |
| GO:1901142 | Insulin metabolic process | Affects phenotype | PMID:34234489 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:34234489; PMID:36038036 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:36038036 |
| GO:1902553 | Positive regulation of catalase activity | Increases phenotype | PMID:34234489 |
| GO:1902722 | Positive regulation of prolactin secretion | Increases phenotype | PMID:27902923 |
| GO:1902884 | Positive regulation of response to oxidative stress | Increases phenotype | PMID:36038036; PMID:36506574 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:36038036 |
| GO:1904662 | Positive regulation of sensory perception of bitter taste | Increases phenotype | PMID:29347925 |
| GO:2000469 | Negative regulation of peroxidase activity | Increases phenotype | PMID:25371773 |
| GO:2000609 | Regulation of thyroid hormone generation | Affects phenotype | PMID:30085217 |
| GO:2000610 | Negative regulation of thyroid hormone generation | Increases phenotype | PMID:27216871; PMID:31414343; PMID:27216871; PMID:34234489; PMID:35101570; PMID:27216871; PMID:38070162; PMID:28973696; PMID:31697382; PMID:34234489; PMID:35101570; PMID:39069214 |
| GO:2000612 | Regulation of thyroid-stimulating hormone secretion | Decreases phenotype | PMID:40023229 |
| GO:2000614 | Positive regulation of thyroid-stimulating hormone secretion | Increases phenotype | PMID:25060363; PMID:27902923; PMID:34234489; PMID:35101570; PMID:34234489; PMID:35101570; PMID:40023229 |
| GO:2000822 | Regulation of behavioral fear response | Affects phenotype | PMID:27216871 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:36506574 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:35871495 |
| GO:2001171 | Positive regulation of atp biosynthetic process | Increases phenotype | PMID:39069214 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.